Israeli company’s Moxo diagnostic assessment test provides uniquely actionable data on attention, hyperactivity, impulsivity and timing for people with ADHD.
While several other Israeli companies are pioneering treatment options for attention-deficit/hyperactivity disorder (ADHD), Nes Ziona-based NeuroTechnology Solutions has put its development efforts into Internet-based software technologies that help clinicians better diagnose and monitor attention problems.
